HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation-Reference-Cited by-同舟云学术

HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation

Published:2022-02-22 Issue:4 Volume:60 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

He Zhenting¹,Gao Yingying²,Li Ting¹,Yu Chaowen³,Ou Liping¹,Luo Chunli¹

Affiliation:

1. Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), School of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, P.R. China

2. Department of Laboratory Diagnosis, People's Hospital of Chongqing Banan District, Chongqing 401320, P.R. China

3. Center for Clinical Molecular Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference53 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Statistical analysis of incidence and mortality of prostate cancer in China, 2015;Fu;Zhonghua Zhong Liu Za Zhi,2020

3. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression;Li;Cell Mol Life Sci,2016

4. Hallmarks of cancer: The next generation;Hanahan;Cell,2011

5. From Krebs to clinic: Glutamine metabolism to cancer therapy;Altman;Nat Rev Cancer,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer metabolites: promising biomarkers for cancer liquid biopsy;Biomarker Research;2023-06-30

2. Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines;Scientific Reports;2022-12-14

3. Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer;Biomolecules;2022-10-28